Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01292629 · ClinicalTrials.gov registry record · NA

Comparison of the Hoya Surgical Optics (HSO) iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical / Literature Controls.

A NA study of Cataract and Aphakia, sponsored by Hoya Surgical Optics.

Completed
Registry status
NA
Development phase
125
Enrollment target
5
Study locations

NCT01292629: Completed NA study of Cataract and Aphakia, sponsored by Hoya Surgical Optics.

NCT01292629 is a NA study of Cataract and Aphakia that has completed, run by Hoya Surgical Optics. The registered enrollment target is 125 participants, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (45% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01292629, a NA study of Cataract and Aphakia, has completed, sponsored by Hoya Surgical Optics.

COMPLETED
Registry status
NA
Development phase
125 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this multi-center clinical trail is to determine the safety and efficacy of the iSert 251 for the correction of aphakia.

Primary Outcome

BEST Spectacle-Correction (ETDRS) Distance Visual Acuity

Conditions Studied

Interventions

  • DEVICE iSert 251 intraocular lens

Study Locations (5)

Florida

  • Katzen Eye Care and Laser Center - Boynton Beach
  • Center for Excellence in Eye Care - Miami

Arizona

  • Schwartz Laser Eye Center - E. Shea Blvd, Suite C101

Indiana

  • Eye Surgeons of Indiana - Indianapolis

Massachusetts

  • Eye Health Vision Centers - North Dartmouth

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2011-02
Est. Completion 2012-05
Phase NA
Hoya Surgical Optics

3 total trials

What the finished NCT01292629 record still lists

NCT01292629 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (45% lower).

The record links to 2 conditions, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which iSert 251 intraocular lens is the first listed.

NCT01292629 lists 5 locations in 4 states (Florida, Arizona, Indiana).

Frequently Asked Questions

What is clinical trial NCT01292629 about?

NCT01292629 is a clinical study titled "Comparison of the Hoya Surgical Optics (HSO) iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical / Literature Controls.". The purpose of this multi-center clinical trail is to determine the safety and efficacy of the iSert 251 for the correction of aphakia.

What is the current status of trial NCT01292629?

This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2011-02. Estimated completion is 2012-05.

What conditions does trial NCT01292629 study?

This clinical trial studies the following conditions: Cataract, Aphakia.

What interventions are being tested in trial NCT01292629?

The interventions under investigation include: iSert 251 intraocular lens (DEVICE).

Who is sponsoring clinical trial NCT01292629?

This trial is sponsored by Hoya Surgical Optics, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01292629 being conducted?

This trial has 5 study locations across Arizona, Florida, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01292629's enrollment target sits among peer trials

125 33rd of 83 higher than 51 of 83 other Cataract trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02717039 · 125 participants

    Pharmacogenomics of Heparin-Induced Thrombocytopenia

  • NCT02763033 · 125 participants · Phase 2

    Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

  • NCT02793999 · 125 participants

    Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

  • NCT03003299 · 125 participants · NA

    PARTNER 3 Trial - Aortic Valve-in-Valve

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01292629, the US trial registry maintained by the National Library of Medicine. NCT01292629 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.